Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

Related Articles by Review for PubMed (Select 10203375)

1.

Hyperhomocysteinemia in chronic renal disease.

Bostom AG, Culleton BF.

J Am Soc Nephrol. 1999 Apr;10(4):891-900. Review. No abstract available.

2.

[Hyperhomocysteinemia as a risk factor for cardiovascular diseases in patients with chronic renal failure].

Małecki R.

Pol Arch Med Wewn. 2000 Oct;104(4):695-701. Review. Polish. No abstract available.

PMID:
11392158
3.

Hyperhomocysteinemia in end stage renal disease: is treatment necessary?

Snavely J.

Nephrol Nurs J. 2002 Apr;29(2):155-60; quiz 161-2. Review.

PMID:
11997950
4.

Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto.

Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D.

Nephrol Dial Transplant. 2000;15 Suppl 5:69-80. Review. No abstract available.

5.

Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.

Perna AF, Capasso R, Acanfora F, Satta E, Lombardi C, Ingrosso D, Violetti E, Romano MM, De Santo NG.

Semin Nephrol. 2006 Jan;26(1):20-3. Review.

PMID:
16412820
6.

Emerging cardiovascular risk factors in end-stage renal disease.

Yaqoob MM.

J Nephrol. 2002 Mar-Apr;15(2):205-8. Review. No abstract available.

PMID:
12018642
7.

[Cardiovascular disorders in chronic renal failure].

Bagriĭ AE.

Ter Arkh. 1998;70(11):80-3. Review. Russian. No abstract available.

PMID:
9949472
8.

Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.

Takamitsu Y, Nakanishi T.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S95-9. Review.

PMID:
11576931
9.

Cardiovascular problems in diabetic patients on renal replacement therapy.

Schömig M, Ritz E.

Nephrol Dial Transplant. 2000;15 Suppl 5:111-6. Review. No abstract available.

10.

Cardiovascular disease in patients with chronic kidney disease. A clinical review.

Kaisar M, Isbel N, Johnson DW.

Minerva Urol Nefrol. 2007 Sep;59(3):281-97. Review.

PMID:
17912225
11.

Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.

Guérin AP, Pannier B, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2006 Mar;15(2):105-10. Review.

PMID:
16481874
12.

[Homocysteine--new risk factor for progression of atherosclerosis and its complications].

Brzósko S, Hryszko T, Małyszko J, Myśliwiec M.

Pol Merkur Lekarski. 2001 Jan;10(55):56-9. Review. Polish.

PMID:
11320555
13.

Hyperhomocysteinemia in end-stage renal failure.

Kes P.

Acta Med Croatica. 2000;54(4-5):175-81. Review.

PMID:
11379482
14.
15.

[Hyperhomocysteinemia in chronic renal failure].

Sydor A, Sułowicz W.

Przegl Lek. 1999;56(7-8):520-4. Review. Polish.

PMID:
10575921
16.

Kidney disease as an independent risk factor for cardiovascular events.

Kumar J, Shah SV.

J Ren Nutr. 2005 Jan;15(1):99-104. Review.

PMID:
15648016
17.

[Homocysteine. The cardiovascular risk factor of the next millennium?].

Suárez García I, Gómez Cerezo JF, Ríos Blanco JJ, Barbado Hernández FJ, Vázquez Rodríguez JJ.

An Med Interna. 2001 Apr;18(4):211-7. Review. Spanish.

PMID:
11496543
18.

[Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].

Cases A, Vera M, López Gómez JM.

Nefrologia. 2002;22 Suppl 1:68-74. Review. Spanish.

PMID:
11987673
19.
20.

[Renal markers and predictors, and renal and cardiovascular risk factors].

Fernández-Andrade C.

Nefrologia. 2002;22 Suppl 1:2-29. Review. Spanish.

PMID:
11987667
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk